drugset / Trial / NCT07798947
A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is an open-label, multicenter, phase II clinical study designed to evaluate the preliminary efficacy, safety, and tolerability of SHR-7787 in combination with Adebrelimab in patients with limited-stage small cell lung cancer.
Timeline
- Start
- 2026-09
- Primary completion
- 2028-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-7787 | Unknown | — | — |
| Background | Adebrelimab | Monoclonal antibody | — | — |